Latest Stories
COVID-19 & CancerFreeGuest Editorial
Prior to the COVID-19 pandemic, NCI estimated that about 3% to 5% of adult cancer patients participated in clinical trials.
Gregory Masters, MD
Principal investigator, NCORP grant; lung cancer specialist, Helen F. Graham Cancer Center and Research Institute, Christiana Care;
Associate professor, Thomas Jefferson University Medical School
